BIBB receives market clearance for EndoDrill GI in the US
The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), which develops and manufactures a new type of electric-driven endoscopic biopsy instrument, EndoDrill®, announces that the Company has now received a 510(k) market clearance from the US Food and Drug Administration (FDA) for EndoDrill[®] GI. The clearance means that BiBB can now market and sell EndoDrill[®] GI in the US, which is by far the largest market in the world for tissue sampling with endoscopic ultrasound (EUS). EndoDrill[®] GI is BiBB's most important product variant, with the widest indication range, that